Cephalon's Patent Experts Barred In FTC Pay-For-Delay Suit
A Pennsylvania federal judge on Wednesday barred Cephalon Inc. from having 10 patent experts testify about the risks of its Provigil patent litigation in the Federal Trade Commission's pay-for-delay suit against...To view the full article, register now.
Already a subscriber? Click here to view full article